Questions and Answers (Workshop III)
M. Blombäck, Y. Laurian(American Red Cross), M.L. Marty, K. Schimpf(Ospedale L. Bonomo), Ettore Randi, J. Eibl, W Rudowski, Tim Holbrook, Ch. Beck, L. Sjamsoedin-Visser, M. Niederberger, J.M. Ziemski, Martin J. Inwood(Miles College), Merle McPherson, Graham Martin(University of Cambridge), Monteiro Marhino, I. Schurwanz, Louis M. Aledort(Icahn School of Medicine at Mount Sinai), W.E.S. Cavalcanti, E. Beikirch, Björn Schlier(Universität Hamburg), C.C. Mintzer, Freya Schnabel(New York University), Peter H. Levine, S Łopaciuk, María de las Mercedes Lomas Campos, B. Justiça, Jonce Nedelkoski, E. Wincott, A. Burzyńska-Klubowska, F. Amorós, H.H. Brackmann, K.M. da Motta, B Dyszy-Laube, Theis Bacher, C. Vermylen, A.F.H. Britten, W. Altendorf, Constantin Smit, Aaron M. Josephson, R.E. George, H. Gadner, Donald E. Colburn, P.M. Mannucci(Ospedale Maggiore), C.J. Cornell(Regional Cancer Center), Peter J.H. Jones(King's College London), J Aznar(Department of Veterans Affairs)
Cited by 0
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
|Journal of Internal Medicine|1994|613
A More Uniform Measurement of Factor VIII Inhibitors
|Thrombosis and Haemostasis|1975|587